Institute for Interdisciplinary
Innovation in healthcare
TMex (Translational Medicine explained) 2025 course announcement
By EATRIS
Want to learn how your research is translated into patients benefit?
Join EATRIS in Barcelona for the Translational Medicine Explained Tmex 2025 course!
Dates: 11-14 November 2025
Place: Barcelona, Spain
Turn science into solutions
The translation of biomedical discoveries into products which provide patient benefit requires a truly multidisciplinary effort. Along the development path, academic / clinical researchers, lawyers, business developers, funders, regulators and patients need to work hand-in hand to allow for a fast and cost-effective process. Many researchers, however, do not have the opportunity to examine the process in more detail and may as a result be missing out on opportunities to take their work further, or work in a less efficient manner.
TMex is an interactive 4-day course, taught by experts who focus on different aspects of the translational path. The course aims to provide hands-on learning, where participants have the opportunity to apply key knowledge and skills to real-life scenarios as they learn them. Open to anyone with an interest in learning more about Translational research and applying it to their own work and research, the course is further enhanced by a series of short e-learning modules which are completed at your own pace prior to attending the face-to-face course.
At the end of the course, participants will be able to:
· Describe the key steps and questions to be addressed in translating scientific discoveries into medical products
· Define the multidisciplinary stakeholders involved in translation and the importance of strong partnerships in improving the pathway
· Recognise the importance of interacting with patients from their viewpoint and demonstrate strategies for engagement
· Examine key translational medicine bottlenecks and opportunities
Additionally, the course will provide participants with the chance to develop their individual professional skills. These will include opportunities to develop their teamwork and communication skills during interactive workshop sessions, through to building their network across all course members and learning more about career options open to them in Translational research.
“The TMex course has given me essential insights about my current research projects, the direction I need to take the research in and also about my future career. I would definitely recommend this course for anyone interested in Translational Medicine!” Rebecca Andersson, IDIBELL, Barcelona, Spain
Une nouvelle ère pour les vaccins et la santé mondiale? A l’Europe de prendre la main – Carte blanche de Michel Goldman
Article du Daily Science

Celebrating 10 Years of the Institute for Interdisciplinary Innovation in Healthcare
A great milestone bringing together experts, researchers, and leaders to reflect on a decade of progress and the challenges ahead in healthcare.

A word from Michel Goldman
Michel Goldman, President of the I3h Institute, introduces the EU4Health Impact and Integration Initiative.
Michel Goldman awarded the 2024 Blaise Pascal Medal laureate in Medicine and Life Sciences.
His commitment to advancing scientific knowledge and fostering interdisciplinary collaboration exemplifies the spirit of the Blaise Pascal Medal, making him a truly deserving recipient of this prestigious honor.
Competition-friendly industrial policy
By Philippe Aghion, Mathias Dewatripont & Patrick Legros
Industrial policy, essential for addressing market failures, encounters concerns regarding protecting inefficient firms. We advocate for competition-friendly industrial policies, underscoring the complementary relationship between industrial and competition policies and the benefits of targeted sector-specific subsidies. We emphasize the significance of market competitiveness for sustainable industrial development, drawing from theoretical models and empirical evidence from China.
Implementing an integrative oncology pathway in a comprehensive cancer center: expert insights and perspectives
Integrative oncology (IO) has evolved into an evidence-informed discipline endorsed by major oncology organizations. However, integrating IO into standard oncology care remains a challenge, often dependent on institutional culture and provider attitudes. This exploratory pilot study aimed to assess healthcare professionals’ (HCPs) knowledge, communication practices, perceived needs, and perspectives regarding IO in a Belgian Comprehensive Cancer Center with no preexisting IO pathway.
3-daagse opleiding “Economische evaluaties van medische interventies”
(Leuven & Sint-Martens-Latem)
Deze interessante en interactieve opleiding wordt in het Nederlands gegeven aan een groep van maximum 20 deelnemers. Hierbij een update van de data waarop de opleiding wordt georganiseerd:
– 10-12 september, 2025 (Leuven – Park Inn by Radisson Leuven) – inschrijvingen open
– 25-27 maart, 2026 (Sint-Martens-Latem – Auberge du Pêcheur) – Nieuwe sessie! Inschrijvingen open
Uitnodiging ME-TA opleiding economische evaluaties (Leuven, 10-12 september 2025)
Uitnodiging ME-TA opleiding economische evaluaties (Sint-Martens-Latem, 25-27 maart 2026)
Donner voix aux patients en oncologie
Florence Horicks of I3h talks about patient advocacy in Esprit Libre

Learning through play: Discovering drug development with Repurpolis Board Game
This morning, we had the pleasure of diving into the fascinating world of drug development through the engaging Repurpolis Board Game organized by Rosan Kreeftmeijer-Vegter. Far more than just entertainment, the game provided an insightful journey, illustrating the critical path a medication must follow before it becomes available to patients.

La lutte contre les futures pandémies doit s’organiser sans les États-Unis
Une tribune du Professeur Michel Goldman (ULB), président de l’Institut I3h, ancien directeur exécutif de l’Initiative Européenne pour les Médicaments Innovants, membre de l’Académie Royale de Médecine de Belgique.
Réflexions sur l’avenir de la médecine inspirées par la pandémie de COVID-19
Comment la pandémie de Covid-19 a-t-elle permis et propulsé des avancés majeures en médecine ? Quelques pistes sur l’évolution de la recherche et des technologies
médicales…

Mathias Dewatripont’s presentation at Collège de France
Mathias Dewatripont presented at an event of the Collège de France in Paris on November 13 on the Future of European Competitiveness, organised by Philippe Aghion, with the presence of Mario Draghi and President Emmanuel Macron.
Our next events
- Register online to our upcoming reading seminar by Ilaria Natali or at ncheikh@i3health.eu before May 15th, 2025